FDA Warns Six Companies of Unapproved and Misbranded Over-the-Counter Pain-Relief Products with Dangerous Excessive Lidocaine Levels

FDA cautions that widely used pain-relief creams could present serious health hazards

The US Food and Drug Administration (FDA) has issued a warning to six companies that sell over-the-counter topical pain-relief products containing lidocaine, a local anesthetic. The FDA has accused these companies of selling unapproved and misbranded products with concentrations of lidocaine that exceed the allowed limit. Jill Furman, director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research, emphasized the risks associated with these products and advised consumers to avoid using them due to their potential harm.

The problem with these products is that they contain excessive amounts of lidocaine, which can lead to serious side effects such as irregular heartbeat, seizures, and breathing difficulties. The FDA recommends avoiding products containing more than 4% lidocaine, refraining from usage on large areas of skin, and avoiding wrapping the product with dressings or plastic wraps. Some of the products cited by the FDA in their warning include TKTX Numb Maximum Strength Pain Reliever, NumbSkin Lidocaine Numbing Creams, and Signature Tattoo Numbing Cream.

Interested individuals can refer to the FDA’s official press release for more detailed information on the specific products mentioned in the warning. It is crucial to heed these warnings to protect your health and well-being while undergoing cosmetic procedures.

The US Food and Drug Administration (FDA) has issued a warning to six companies that sell over-the-counter topical pain-relief products containing lidocaine, a local anesthetic. The FDA has accused these companies of selling unapproved and misbranded products with concentrations of lidocaine that exceed the allowed limit. Jill Furman, director of the Office of Compliance in…

Leave a Reply